Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;89(7):1996-2019.
doi: 10.1111/bcp.15418. Epub 2022 Jun 19.

Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis-inspired systematic review

Affiliations
Free article

Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis-inspired systematic review

Stijn Hogervorst et al. Br J Clin Pharmacol. 2023 Jul.
Free article

Erratum in

Abstract

Upscaling of medication adherence interventions to routine care is still challenging. This realist theory-inspired review aimed to assess which intervention aspects are potentially important for the scalability of effective cardiovascular disease (CVD) medication adherence interventions and how they are reported in effectiveness studies. A total of 4097 articles from four databases were screened of which ultimately 31 studies were included. Relevant information on scalability was extracted using a theoretic framework based on the scalability assessment tool used in the QUALIDEC study for the following domains: (i) innovation, (ii) implementers and patients, (iii) adopting organizations and health system, and (iv) socio-political context. Extracted articles were analysed for themes and chains of inference, which were grouped based on commonality and source of evidence to form new hypotheses. Six different domains relevant for scalability of adherence interventions were identified: (1) Complexity of the intervention; (2) training; (3) customization of the intervention; (4) drivers of the intervention; (5) technical interventions; and (6) stakeholder involvement. These six domains might be useful for the development of more scalable interventions by bridging the gap between research and practice. Data relevant for scalability is not well reported on in effectiveness trials for CVD medication adherence interventions and only limited data on scalability has been published in additional papers. We believe the adoption and reach of effective CVD medication adherence interventions will improve with increased awareness for the necessity of scalability in all phases of intervention development.

Keywords: adherence; cardiovascular; clinical pharmacology; primary care; realist synthesis.

PubMed Disclaimer

References

REFERENCES

    1. WHO. (2021). Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases.... Published June 11, 2021. Accessed May 31, 2022.
    1. Ferdinand KC, Senatore FF, Clayton-Jeter H, et al. Improving medication adherence in cardiometabolic disease. J Am Coll Cardiol. 2017;69(4):437-451. doi:10.1016/j.jacc.2016.11.034
    1. Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013;55(6):590-600. doi:10.1016/j.pcad.2013.02.001
    1. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940-2948. doi:10.1093/eurheartj/eht295
    1. Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health (Oxf). 2019;41(1):e84-e94. doi:10.1093/pubmed/fdy088

Publication types

LinkOut - more resources